CD73 and CD29 concurrently mediate the mechanically induced decrease of migratory capacity of mesenchymal stromal cells

The assumption that mesenchymal stromal cell (MSC)-based-therapies are capable of augmenting physiological regeneration processes has fostered intensive basic and clinical research activities. However, to achieve sustained therapeutic success in vivo, not only the biological, but also the mechanical...

Full description

Bibliographic Details
Main Authors: A Ode, J Kopf, A Kurtz, K Schmidt-Bleek, P Schrade, P Kolar, F Buttgereit, K Lehmann, DW Hutmacher, GN Duda, G Kasper
Format: Article
Language:English
Published: AO Research Institute Davos 2011-07-01
Series:European Cells & Materials
Subjects:
Online Access:http://www.ecmjournal.org/journal/papers/vol022/pdf/v022a03.pdf